Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of
circulating tumor-DNA (ct-DNA)
epidermal growth factor receptor (EGFR)
massive parallel sequencing (MPS)
resistance-inducing mutation
tyrosine-kinase Inhibitors
Journal
Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965
Informations de publication
Date de publication:
17 Mar 2020
17 Mar 2020
Historique:
received:
08
01
2020
accepted:
17
02
2020
entrez:
28
3
2020
pubmed:
28
3
2020
medline:
28
3
2020
Statut:
epublish
Résumé
In Non-Small-Cell Lung Cancer (NSCLC) patients treated with Tyrosine Kinase-Inhibitors (TKIs) therapy, the emergence of acquired resistance can be investigated by plasma monitoring of circulating tumor DNA (ctDNA). A series of 116 patients with
Identifiants
pubmed: 32215186
doi: 10.18632/oncotarget.27517
pii: 27517
pmc: PMC7082112
doi:
Types de publication
Journal Article
Langues
eng
Pagination
982-991Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST The authors have no conflicts of interest.
Références
Lung Cancer. 2013 Nov;82(2):294-8
pubmed: 24035188
Cancer. 2020 Jan 15;126(2):373-380
pubmed: 31769875
Clin Cancer Res. 2011 Mar 1;17(5):1169-80
pubmed: 21248300
J Thorac Oncol. 2015 Oct;10(10):1437-43
pubmed: 26295376
Clin Cancer Res. 2019 Nov 15;25(22):6644-6652
pubmed: 31439584
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Clin Cancer Res. 2011 Mar 15;17(6):1616-22
pubmed: 21135146
Nat Med. 2014 May;20(5):548-54
pubmed: 24705333
N Engl J Med. 2005 Feb 24;352(8):786-92
pubmed: 15728811
J Clin Oncol. 2012 Jun 10;30(17):2063-9
pubmed: 22547605
PLoS Med. 2005 Mar;2(3):e73
pubmed: 15737014
JAMA Oncol. 2019 Feb 1;5(2):173-180
pubmed: 30325992
Clin Cancer Res. 2015 Jul 15;21(14):3196-203
pubmed: 25829397
ACS Med Chem Lett. 2015 Dec 18;7(1):2-5
pubmed: 26819655
J Med Chem. 2014 Oct 23;57(20):8249-67
pubmed: 25271963
J Thorac Oncol. 2014 Sep;9(9):1345-53
pubmed: 25122430
N Engl J Med. 2009 Sep 3;361(10):947-57
pubmed: 19692680
Clin Cancer Res. 2013 Apr 15;19(8):2240-7
pubmed: 23470965
N Engl J Med. 2010 Jun 24;362(25):2380-8
pubmed: 20573926
N Engl J Med. 2020 Jan 2;382(1):41-50
pubmed: 31751012
ACS Med Chem Lett. 2019 Aug 02;10(9):1322-1327
pubmed: 31531204
Lancet Oncol. 2020 Mar;21(3):373-386
pubmed: 32027846
Lancet Oncol. 2010 Feb;11(2):121-8
pubmed: 20022809